Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Single Molecule Real Time Sequencing Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
Fueled by significant progress in DNA sequencing chemistry and the expanding scope of genomic research initiatives, the single molecule real-time sequencing market experienced robust expansion. This growth trajectory is projected to continue, with market value escalating from $3.43 billion in 2025 to an estimated $3.73 billion in 2026, reflecting a compound annual growth rate of 8.7%. Key drivers underpinning this expansion during the preceding period included the increasing adoption of next-generation sequencing platforms, augmented investment in genetic studies, and the enhanced utilization of long-read data within the research community.
The market for single-molecule real-time sequencing is poised for substantial expansion in the upcoming years, projecting a reach of $5.15 billion by 2030, fueled by a compound annual growth rate of 8.4%. This upward trajectory during the projected timeframe is largely propelled by an escalating need for thorough genome examinations, wider clinical embrace of long-read sequencing techniques, broadening research avenues in epigenetics, the increasing incorporation of artificial intelligence in genomic data analysis, and a consistent improvement in minimizing sequencing errors. Key developments anticipated over this forecast period encompass a greater uptake of long-read sequencing methodologies, a surge in the demand for immediate DNA analysis, enhanced utilization of cloud-based bioinformatics solutions, the proliferation of applications requiring precise genome assembly, and a heightened emphasis on identifying structural variations within genomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20631&type=smp
Single Molecule Real Time Sequencing Market Opportunity Drivers: What Is Creating New Revenue Potential?
An escalating incidence of neurological disorders is anticipated to catalyze the expansion of the single molecule real-time sequencing market. These disorders, which impact the intricate network of the nervous system – encompassing the brain, spinal cord, and peripheral nerves – manifest in varied impairments affecting mobility, sensory perception, cognitive functions, and motor control. Conditions such as Alzheimer’s, Parkinson’s disease, stroke, and epilepsy represent prominent examples of neurological ailments. Factors contributing to this surge include an increasing elderly demographic, heightened public and professional awareness, advancements in diagnostic capabilities, and environmental influences. Single-molecule real-time (SMRT) sequencing technology offers in-depth genetic insights indispensable for comprehending and managing neurological challenges. To illustrate, a May 2024 report from the Alzheimer’s Association, a non-profit organization focused on Alzheimer’s research and support in the United States, indicated a rise in American individuals aged 65 and above diagnosed with Alzheimer’s, climbing from 6.5 million in 2022 to 6.9 million in 2024. Consequently, the increasing occurrence of neurological diseases is poised to stimulate growth within the single molecule real-time sequencing sector.
Single Molecule Real Time Sequencing Market Segmentation And Category Breakdown
The single molecule real time sequencing market covered in this report is segmented –
1) By Workflow Stage: Pre-Sequencing, Sequencing, Data Analysis
2) By Product: Consumable, Instrument, Services
3) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications
4) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End Users
Subsegments:
1) By Pre-Sequencing: Library Preparation Kits, DNA/RNA Extraction And Purification Products, Quality Control And Quantification Tools
2) By Sequencing: Real-Time Sequencing Systems, Portable Sequencing Devices, High-Throughput Sequencing Platforms
3) By Data Analysis: Software For Data Processing, Bioinformatics Tools, Cloud-Based Data Analysis Solutions
Single Molecule Real Time Sequencing Market Innovation Trends Driving Future Development
Companies actively participating in the single-molecule real-time sequencing arena are prioritizing the creation of cutting-edge technologies, specifically benchtop long-read sequencers that offer superior read accuracy, as a means to enhance their market standing. Such a sequencer is characterized as a compact piece of laboratory equipment designed for lengthy DNA sequencing with exceptional precision and adequate efficiency, thereby extending the reach of sophisticated sequencing beyond specialized genomics facilities. As an illustration, Pacific Biosciences, an American firm specializing in genomics, introduced the Vega benchtop sequencer in November of 2024. This instrument is capable of generating 60 gigabases of data per cycle, provides exceptionally precise long reads (referred to as HiFi), and facilitates the acquisition of genomic, transcriptomic, and epigenetic information even within modest laboratory settings. The advantages conferred by these features include an expanded range of potential users, faster integration into clinical and research environments, and a lowering of the hurdles for initial implementation, though the expense associated with regular operation might remain a consideration for smaller laboratories.
Single Molecule Real Time Sequencing Market Competitive Analysis Of Major Industry Participants
Major companies operating in the single molecule real time sequencing market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Pacific Biosciences of California Inc., Oxford Nanopore Technologies Limited, Illumina Inc., BGI Genomics Co. Ltd., Novogene Corporation, New England Biolabs Inc., Zymo Research Corporation, GENEWIZ Inc., Dovetail Genomics LLC, Singular Genomics Systems Inc., Horizon Discovery Group plc, Asuragen Inc., LGC Limited, Tecan Group Ltd, 10x Genomics Inc.
Access The Complete Single Molecule Real Time Sequencing Market Report:
Single Molecule Real Time Sequencing Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the single molecule real time sequencing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the single molecule real time sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
